Last Price
68.62
Today's Change
+3.63 (5.58%)
Day's Change
65.80 - 69.92
Trading Volume
16,199,844
Market Cap
10 Billion
Shares Outstanding
152 Million
Avg Volume
6,419,405
Avg Price (50 Days)
46.42
Avg Price (200 Days)
46.85
PE Ratio
-13.24
EPS
-5.16
Earnings Announcement
26-Feb-2025
Previous Close
64.99
Open
66.70
Day's Range
65.8 - 69.92
Year Range
22.89 - 79.49
Trading Volume
16,199,844
1 Day Change
5.14%
5 Day Change
27.41%
1 Month Change
82.12%
3 Month Change
-7.37%
6 Month Change
76.34%
Ytd Change
99.50%
1 Year Change
69.76%
3 Year Change
69.76%
5 Year Change
69.76%
10 Year Change
69.76%
Max Change
69.76%
No result.
Sector: Healthcare - Healthcare
Industry: Healthcare
Description:
Tempus AI, Inc operates as a healthcare technology company. It engages in providing next generation sequencing diagnostics, polymerase chain reaction profiling, molecular genotyping, and other anatomic and molecular pathology testing to healthcare providers, pharmaceutical companies, biotechnology companies, researchers, and other third parties. The company also offers Insights, a license library of linked clinical, molecular, and imaging de-identified data, as well as a suite of analytical services to analytic and cloud-and-compute tools to pharmaceutical and biotechnology companies; and Trials that provides clinical trial matching services to pharmaceutical companies. In addition, it operates Next; Algos, a suite of algorithmic tests in oncology; Hub, a desktop and mobile platform for ordering, managing, and receiving tests and patient results; and Lens, a platform for researchers and scientists to find, access, and analyze Tempus data. The company was formerly known as Tempus Labs, Inc. and changed its name to Tempus AI, Inc in January 2023. Tempus AI, Inc was incorporated in 2015 and is headquartered in Chicago, Illinois.